顺式17-己糖烯酸 | 66274-43-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 顺式17-己糖烯酸
• 英文名称: hexacos-17c-enoic acid
• 英文别名: Hexacos-17c-ensaeure；Ximensaeure；cis-17-Hexacosensaeure；cis-17-Hexacosensaeure；Ximenic acid；(Z)-hexacos-17-enoic acid
• CAS: 66274-43-9
• 化学式: C₂₆H₅₀O₂
• 分子量: 394.682
• InChiKey: RQIDQEBURXNDKG-KTKRTIGZSA-N

物化性质

• 沸点：
  504.3±19.0 °C(Predicted)
• 密度：
  0.885±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  10.8
• 重原子数：
  28
• 可旋转键数：
  23
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  顺式17-己糖烯酸 在 platinum(IV) oxide 、 乙醇 作用下， 生成 蜡酸
  参考文献：
  名称：

  Puntambekar-Krishna, Journal of the Indian Chemical Society, vol. 14, p. 272

  摘要：

  DOI：

文献信息

• BONE METABOLISM IMPROVING AGENTS
  申请人：The Nisshin OilliO Group, Ltd.

  公开号：EP1380293A9

  公开（公告）日：2009-09-23

  The present invention relates to an improver for bone metabolism comprising one or at least two of chain isoprenoid fatty acid esters and preferably to an improver for bone metabolism whose improving effect is ascribable to the bone absorption-inhibitory action and/or the bone formation-promoting action of the esters.

  本发明涉及一种骨代谢改善剂，包括链异戊二烯脂肪酸酯中的一种或至少两种，并且更倾向于一种骨代谢改善剂，其改善作用归因于酯的抑制骨吸收作用和/或促进骨形成作用。
• Preparation of saccharide esters
  申请人：Scherl Franz-Xaver

  公开号：US20050019296A1

  公开（公告）日：2005-01-27

  A process for the preparation of saccharide esters by reacting saccharides with activated carboxylic acids in a dipolar-aprotic solvent and in the absence of a basic amine compound is described.

  本发明涉及一种通过在双极-无极溶剂中与活性羧酸反应制备糖苷酯的方法，且在无碱性胺类化合物存在的情况下进行。
• Agent for improving bone metabolism
  申请人：The Nisshin Oillio, Ltd.

  公开号：US20040058995A1

  公开（公告）日：2004-03-25

  The present invention relates to an improver for bone metabolism comprising one or at least two of chain isoprenoid fatty acid esters and preferably to an improver for bone metabolism whose improving effect is ascribable to the bone absorption-inhibitory action and/or the bone formation-promoting action of the esters.

  本发明涉及一种骨代谢改善剂，其包括一种或至少两种链状异戊二烯脂肪酸酯，并且更倾向于一种骨代谢改善剂，其改善效果归因于这些酯的抑制骨吸收作用和/或促进骨形成作用。
• DEVICE AND METHOD FOR SOLUBILIZING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO-OR NANOEMULSIFICATION
  申请人：Dietz Ulrich

  公开号：US20130090488A1

  公开（公告）日：2013-04-11

  The present invention is directed to solubilizing compounds, a device and a method for solubilizing and removing carboxylic acids and especially fatty acids from oils, fats, aqueous emulsion, aqueous media and organic solutions. Devices utilizing the inventive method shall be used for separating carboxylic acids from oils, fats, aqueous emulsion, lipophilic media or organic solutions, respectively by preparing an aqueous micro- or nanoemulsion of the carboxylic acids especially the fatty acids and the solubilizing compound which contains at least one amidino and/or gianidino group. Solubilization effects of solubilizing compounds combined with the inventive use of separation methods for carboxylic acids can be used to treat persons in need of removal of fatty acids or analyze carboxylic acids from blood or process other solutions in food, pharmacy, chemistry, bio fuel industry or other industrial processings.

  本发明涉及溶解化合物、用于从油、脂肪、水乳液、水介质和有机溶液中溶解和去除羧酸，特别是脂肪酸的装置和方法。采用本发明方法的装置将用于通过制备羧酸特别是脂肪酸和含有至少一种氨基甲酰基和/或肼基团的溶解化合物的水微观或纳米乳液，分离油、脂肪、水乳液、亲脂性介质或有机溶液中的羧酸。溶解化合物的溶解效果与本发明所述的羧酸分离方法相结合，可用于治疗需要去除脂肪酸或从血液中分析羧酸或处理食品、药品、化学、生物燃料工业或其他工业加工过程中的其他溶液的人员。
• Polyunsaturated acids having vasokinetic action and pharmaceutical and cosmetic formulations containing them
  申请人：INDENA S.p.A.

  公开号：EP0304603A1

  公开（公告）日：1989-03-01

  Some polyunsaturated acids (ximeninic acid, γ-homo-linolenic acid, eicosapentaenoic acid), suitably formulated and administered by the topical route, possibly in form of glicerids or of complexes with phospholipids, have vasokinetic and vasodilative properties.

  某些多不饱和酸（西门酸、γ-同型亚麻酸、二十碳五烯酸），经适当配制并通过局部途径给药，可能以格列卫形式或与磷脂的复合物形式给药，具有促进血管运动和扩张血管的特性。